Surgical treatment of metastatic pulmonary soft-tissue sarcoma

Celia Chao, Melvyn Goldberg

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We review the current literature on the use of pulmonary metastasectomy in patients with soft-tissue sarcoma, as well as survival data after such treatment. Osteogenic sarcoma is not included in this discussion.

Original languageEnglish (US)
Pages (from-to)835-841
Number of pages7
JournalOncology
Volume14
Issue number6
StatePublished - 2000
Externally publishedYes

Fingerprint

Sarcoma
Lung
Metastasectomy
Neoplasm Metastasis
Osteosarcoma
Patient Selection
Radiotherapy
Therapeutics
Drug Therapy
Survival
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Surgical treatment of metastatic pulmonary soft-tissue sarcoma. / Chao, Celia; Goldberg, Melvyn.

In: Oncology, Vol. 14, No. 6, 2000, p. 835-841.

Research output: Contribution to journalArticle

Chao, C & Goldberg, M 2000, 'Surgical treatment of metastatic pulmonary soft-tissue sarcoma', Oncology, vol. 14, no. 6, pp. 835-841.
Chao, Celia ; Goldberg, Melvyn. / Surgical treatment of metastatic pulmonary soft-tissue sarcoma. In: Oncology. 2000 ; Vol. 14, No. 6. pp. 835-841.
@article{c497a4e1a68b48258a9441287b37dd74,
title = "Surgical treatment of metastatic pulmonary soft-tissue sarcoma",
abstract = "The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We review the current literature on the use of pulmonary metastasectomy in patients with soft-tissue sarcoma, as well as survival data after such treatment. Osteogenic sarcoma is not included in this discussion.",
author = "Celia Chao and Melvyn Goldberg",
year = "2000",
language = "English (US)",
volume = "14",
pages = "835--841",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "6",

}

TY - JOUR

T1 - Surgical treatment of metastatic pulmonary soft-tissue sarcoma

AU - Chao, Celia

AU - Goldberg, Melvyn

PY - 2000

Y1 - 2000

N2 - The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We review the current literature on the use of pulmonary metastasectomy in patients with soft-tissue sarcoma, as well as survival data after such treatment. Osteogenic sarcoma is not included in this discussion.

AB - The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We review the current literature on the use of pulmonary metastasectomy in patients with soft-tissue sarcoma, as well as survival data after such treatment. Osteogenic sarcoma is not included in this discussion.

UR - http://www.scopus.com/inward/record.url?scp=0034201592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034201592&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 835

EP - 841

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 6

ER -